Evaluation of Prepubertal Patients with Suspected Neurosecretory Dysfunction of Growth Hormone Secretion: Diagnostic Steps and Treatment Response

Figure 7

(a) Change in height from baseline to end of treatment in the patients who already finished therapy (mean, maximal and minimal levels); (b) change of height from baseline to 4 years of therapy in all children treated for at least 4 years.